ResearcherRoche Pharma AG (Germany)No recent work listed

Juergen M. Schanzer

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111630699. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2016: 1 paper

Papers 1

XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatme… Co-author DOI 10.1080/19420862.2016.1160989 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Christian Klein · 1 shared paper, 2016 · strength 0.05
- Paper XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and en… DOI 10.1080/19420862.2016.1160989 ↗
Peng Wang · 1 shared paper, 2016 · strength 0.05
- Paper XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and en… DOI 10.1080/19420862.2016.1160989 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.